Carol Giltner Gallagher
CIK 1329959 · SVP, Corp Dev & Comm Affairs · last filed 2026-06-05
Carol Giltner Gallagher is a SVP, Corp Dev & Comm Affairs who has filed 52 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for PMVP, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$2.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.64M
9
52
-$1.99M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PMVP | Director | — | $1.11 | — | $0 | 5 | 2026-06-05 |
| ATRA | Director | 95,668 | $10.41 | $995.9K | -$1.99M | 30 | 2025-06-12 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Director | 6,808 | $58.70 | $399.6K | $0 | 3 | 2024-01-23 |
| Frazier Lifesciences Acquisition Corp (FLACW) Delisted | Director | — | $0.80 | — | $0 | 1 | 2022-11-23 |
| Turning Point Therapeutics, Inc. (TPTX) Delisted | Director | — | $76.01 | — | $0 | 4 | 2022-08-17 |
| CERT | Director | 7,059 | $5.20 | $36.7K | $0 | 1 | 2021-06-16 |
| Tempest Therapeutics, Inc. (MLND) Delisted | Director | 31,933 | $15.90 | $507.7K | $0 | 4 | 2020-06-23 |
| ANAB | Director | 64,296 | $56.07 | $3.61M | $0 | 3 | 2018-02-06 |
| ANADYS PHARMACEUTICALS INC (ANDS) Delisted | SVP, Corp Dev & Comm Affairs | — | — | — | $0 | 1 | 2007-05-18 |
Recent Filings
52 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | PMVP | Mixed | — | $0 | EDGAR |
| 2025-06-12 | ATRA | Grant (A) | +7,828 | $0 | EDGAR |
| 2025-06-09 | PMVP | Mixed | — | $0 | EDGAR |
| 2024-06-10 | PMVP | Mixed | — | $0 | EDGAR |
| 2024-04-02 | ATRA | Grant (A) | +150,000 | $0 | EDGAR |
| 2024-01-23 | Mirati Therapeutics, Inc. (MRTX) Delisted | Disp (D) | −14,363 | $0 | EDGAR |
| 2024-01-03 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +6,808 | $400.0K | EDGAR |
| 2023-11-15 | ATRA | Buy (P) | +270,000 | $68.2K | EDGAR |
| 2023-06-23 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | +7,555 | $0 | EDGAR |
| 2023-06-12 | PMVP | Mixed | — | $0 | EDGAR |